U.S. Hematology Brand Lead, Navtemadlin

Title: U.S. Hematology Brand Lead, Navtemadlin Company: Ipsen Biopharmaceuticals Inc. About Ipsen: Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs in the U.S., France and the U.K, we tackle areas of high unmet medical need through research and innovation.

Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries. We build a workplace that champions human-centric leadership and fosters a culture of collaboration, excellence and impact. At Ipsen, every individual is empowered to be their true selves, grow and thrive alongside the company’s success. Join us on our journey towards sustainable growth, creating real impact on patients and society!

For more information, visit us at https://www.ipsen.com/   and follow our latest news on LinkedIn and Instagram . Job Description: The U.S. Hematology Brand Lead, Navtemadlin, is the senior commercial leader accountable for shaping and executing the U.S. launch of Navtemadlin within the US Oncology franchise. This role owns the integrated U.S. brand strategy, launch roadmap, market-shaping agenda, and commercial execution across relevant customer and stakeholder segments upon launch.

The Brand Lead will translate scientific and market insights into a differentiated launch strategy for an oral hematology therapy and mobilize cross-functional teams to deliver launch readiness, adoption, and sustainable growth. Success requires deep hematology/oncology expertise and commercialization experience, proven launch leadership, ability to build and manage teams, market-shaping capability, scientific acumen, and the ability to influence senior stakeholders and deliver results through a matrixed organization.

WHAT - Main Responsibilities Brand Strategy Own and drive the U.S. brand strategy, including pre-launch planning, positioning, value narrative, and long-range plan for Navtemadlin. Lead the end-to-end U.S. launch strategy and integrated launch plan, translating strategic choices into clear workstreams, milestones, accountabilities, and decision points. Ensure a single, differentiated, and scientifically credible brand narrative across customer segments, channels, and cross-functional partners.

Lead scenario planning for key clinical, regulatory, competitive, access, and operational uncertainties, and drive timely mitigation and course correction. Build a lifecycle strategy that anticipates future evidence, indications, combinations, customer needs, and competitive developments. Develop and execute a comprehensive market-shaping strategy to build disease awareness, clarify the patient journey, strengthen diagnostic and referral pathways, and prepare the market for launch.

Identify and prioritize the stakeholders, institutions, care settings, and treatment decision points that will most influence launch success. Generate actionable insights from hematologists/oncologists, patients, caregivers, advocacy organizations, payers, health systems, and other relevant stakeholders. Partner with Medical Affairs and Market Access to address evidence, education, access, and adoption barriers within appropriate functional and compliance boundaries.

Define the commercial model for an oral therapy, including customer engagement, patient identification, treatment initiation, adherence, persistence, distribution, access, and support considerations. Shape an integrated professional and patient/caregiver experience that is consistent, relevant, and measurable across personal and non-personal channels. Commercial Accountability Own launch objectives, performance indicators, critical success factors, and the commercial operating plan for the brand.

Own the U.S. brand P&L assumptions, commercial investment strategy, and long-term business p